Literature DB >> 7198939

High-dose cisplatin for lung cancer.

V K Bhuchar, V J Lanzotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7198939

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

1.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.

Authors:  D R Gandara; E A Perez; H Wold; V Caggiano; M Malec; D K Ahn; F Meyers; R W Carlson
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.

Authors:  N Niederle; J Schütte; W Krischke; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-08-16

Review 4.  Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.

Authors:  H Nakagawa; Y Miyawaki; T Fujita; S Kubo; K Tokiyoshi; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 5.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. II: Clinical effects.

Authors:  H Nakagawa; T Fujita; S Izumimoto; Y Miyawaki; S Kubo; Y Nakajima; K Tsuruzono; K Kodama; M Higashiyama; O Doi
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.